Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.009 | 0.109 | 0.1359 |
Treponema pallidum | hypothetical protein | 0.0319 | 0.8019 | 1 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0082 | 0.0847 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.01 | 0.141 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.141 | 0.1071 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0082 | 0.0847 | 0.0984 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0163 | 0.3308 | 0.5562 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0082 | 0.0847 | 0.0984 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0082 | 0.0867 | 0.1307 |
Brugia malayi | Matrixin family protein | 0.0074 | 0.0606 | 0.0409 |
Echinococcus multilocularis | adam 17 protease | 0.0183 | 0.3914 | 0.4547 |
Echinococcus granulosus | a disintegrin and metalloproteinase with | 0.0087 | 0.0998 | 0.1159 |
Brugia malayi | Probable ClpP-like protease | 0.0082 | 0.0847 | 0.0845 |
Echinococcus multilocularis | tar DNA binding protein | 0.0066 | 0.038 | 0.0442 |
Loa Loa (eye worm) | matrixin family protein | 0.0163 | 0.3308 | 0.3043 |
Loa Loa (eye worm) | matrixin family protein | 0.0249 | 0.5907 | 0.5745 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0082 | 0.0847 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0104 | 0.1533 | 0.3094 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.009 | 0.109 | 0.1284 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.0606 | 0.0235 |
Plasmodium vivax | nicotinate-nucleotide adenylyltransferase, putative | 0.0319 | 0.8019 | 1 |
Mycobacterium leprae | PROBABLE NICOTINATE-NUCLEOTIDE ADENYLYLTRANSFERASE NADD (DEAMIDO-NAD(+) PYROPHOSPHORYLASE) (DEAMIDO-NAD(+) DIPHOSPHORYLASE) (NIC | 0.0319 | 0.8019 | 1 |
Plasmodium falciparum | nicotinamide/nicotinic acid mononucleotide adenylyltransferase | 0.0319 | 0.8019 | 1 |
Mycobacterium tuberculosis | Probable nicotinate-nucleotide adenylyltransferase NadD (deamido-NAD(+) pyrophosphorylase) (deamido-NAD(+) diphosphorylase) (nic | 0.0319 | 0.8019 | 1 |
Echinococcus multilocularis | Blood coagulation inhibitor, Disintegrin | 0.0115 | 0.1856 | 0.2156 |
Mycobacterium ulcerans | bifunctional nicotinate-nucleotide adenylyltransferase NadD/hypothetical protein | 0.0319 | 0.8019 | 1 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0339 | 0.8608 | 1 |
Loa Loa (eye worm) | matrix metalloproteinase | 0.0074 | 0.0606 | 0.0235 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0339 | 0.8608 | 1 |
Brugia malayi | Matrixin family protein | 0.0074 | 0.0606 | 0.0409 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 0.2762 | 0.2476 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.01 | 0.141 | 1 |
Echinococcus multilocularis | geminin | 0.019 | 0.4107 | 0.4771 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0082 | 0.0847 | 0.1056 |
Brugia malayi | Matrixin family protein | 0.0074 | 0.0606 | 0.0409 |
Brugia malayi | Matrixin family protein | 0.0074 | 0.0606 | 0.0409 |
Brugia malayi | metalloprotease disintegrin 16 with thrombospondin type I motif | 0.0087 | 0.0998 | 0.1117 |
Echinococcus multilocularis | dna polymerase eta | 0.01 | 0.141 | 0.1638 |
Brugia malayi | Matrixin family protein | 0.0249 | 0.5907 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.0847 | 0.0486 |
Schistosoma mansoni | DNA polymerase eta | 0.01 | 0.141 | 0.2764 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.109 | 0.0738 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.01 | 0.141 | 0.1864 |
Echinococcus granulosus | geminin | 0.019 | 0.4107 | 0.4771 |
Echinococcus granulosus | Blood coagulation inhibitor Disintegrin | 0.0115 | 0.1856 | 0.2156 |
Schistosoma mansoni | hypothetical protein | 0.019 | 0.4107 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.0606 | 0.0235 |
Echinococcus multilocularis | a disintegrin and metalloproteinase with | 0.0087 | 0.0998 | 0.1159 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0082 | 0.0847 | 1 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0082 | 0.0847 | 0.1253 |
Schistosoma mansoni | ADAM17 peptidase (M12 family) | 0.0183 | 0.3914 | 0.9482 |
Onchocerca volvulus | Matrilysin homolog | 0.0235 | 0.5463 | 1 |
Brugia malayi | Hemopexin family protein | 0.0104 | 0.1533 | 0.2086 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.009 | 0.109 | 0.1359 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0082 | 0.0847 | 0.5 |
Mycobacterium ulcerans | hydrolase | 0.009 | 0.109 | 0.0338 |
Schistosoma mansoni | hypothetical protein | 0.019 | 0.4107 | 1 |
Schistosoma mansoni | ADAMTS5 peptidase (M12 family) | 0.0087 | 0.0998 | 0.1657 |
Echinococcus granulosus | tar DNA binding protein | 0.0066 | 0.038 | 0.0442 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0145 | 0.2762 | 0.639 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.01 | 0.141 | 0.5 |
Echinococcus granulosus | adam 17 protease | 0.0201 | 0.4465 | 0.5187 |
Onchocerca volvulus | 0.0104 | 0.1533 | 0.1908 | |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0082 | 0.0847 | 1 |
Echinococcus granulosus | dna polymerase eta | 0.01 | 0.141 | 0.1638 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 20 uM | Inhibition of MDH2 (unknown origin) pre-incubated for 1 hr followed by malate and NAD+ addition | ChEMBL. | 25356789 |
IC50 (binding) | > 30 uM | Inhibition of HIF-1alpha in human HCT116 cells incubated for 12 hrs under hypoxic conditions by Western blotting and HRE-luciferase reporter assay | ChEMBL. | 25356789 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.